Traws Pharma, Inc. (TRAW) Dividend History

Traws Pharma, Inc. (TRAW) is a biotechnology company focusing on the development of innovative pharmaceutical products. The company is dedicated to researching and bringing to market therapies aimed at addressing unmet medical needs, with a particular emphasis on novel formulations and delivery systems. Traws Pharma aims to leverage cutting-edge science to improve patient outcomes across various therapeutic areas.

12 Penns Trail, Newtown, PA, 18940
Phone: 267-759-3680
Website: https://www.onconova.com

Dividend History

Traws Pharma, Inc. currently does not pay dividends

Company News

Traws Pharma Announces Publication of Compelling Efficacy data in RDEB SCC Patients Treated with Legacy Oncology Drug Rigosertib

Traws Pharma announces the publication of positive clinical data for its legacy oncology drug rigosertib in treating recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma (RDEB SCC), a rare and aggressive form of skin cancer.

GlobeNewswire Inc.
Traws Pharma Reports First Quarter 2024 Financial Results and Provides Business Update

Traws Pharma Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire Inc.
Heron Therapeutics (HRTX) Reports Q1 Loss, Tops Revenue Estimates

Heron Therapeutics (HRTX) delivered earnings and revenue surprises of 75% and 6.68%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research

Featured Companies: HRTX
Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy

Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy

GlobeNewswire Inc.
Why Flora Growth Shares Are Trading Lower By Around 20%; Here Are 20 Stocks Moving Premarket

Shares of Flora Growth Corp. (NASDAQ: FLGC) fell sharply in today’s pre-market trading after the company reported the launch of proposed underwritten public offering of common shares. Flora Growth shares tumbled 20.2% to $2.13 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers HWH International Inc. (NASDAQ: HWH) rose 175% to $4.32 in pre-market trading. Zhongchao Inc. (NASDAQ: ZCMD) gained 43% to $2.18 in pre-market trading after gaining 22% on Wednesday. Brooge Energy Limited (NASDAQ: BROG) gained 26.4% to $2.39 in pre-market trading after dipping over 20% on Wednesday. Sintx Technologies, Inc. (NASDAQ: SINT) shares rose 23.5% to $0.0284 in pre-market trading. SiNtx Technologies shares fell around 45% on Wednesday after the company announced pricing of a $1.5 million public offering of common stock. Addex Therapeutics Ltd (NASDAQ: ADXN) shares rose 15.1% to $17.84 in pre-market trading. Addex Therapeutics shares gained 18% on Wednesday after the company and funds affiliated with Perceptive Advisors announced the launch of Neurosterix.. Destiny Tech100 Inc. (NASDAQ: DXYZ) shares ...

Benzinga

Featured Companies: BROG DXYZ FLGC HWH LEVI ONMD RELI SINT SLP SRM VVPR XTIA ZCMD

Dividend data last updated 06/07/2025 07:14:09 UTC